Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 13,072,993
- Share change
- +190,563
- Total reported value
- $294,217,317
- Price per share
- $22.50
- Number of holders
- 43
- Value change
- +$4,316,413
- Number of buys
- 18
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
7%
|
2,987,331
|
$64,377,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
3/4/5
|
Company · 10%+ Owner |
4.7%
|
2,013,601
|
$43,393,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.4%
|
1,444,831
|
$31,136,000 | — | 30 Sep 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
3.3%
|
1,417,157
|
$30,540,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.1%
|
1,296,416
|
$27,937,000 | — | 30 Sep 2021 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
1.5%
|
650,780
|
$14,024,000 | — | 30 Sep 2021 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1.2%
|
514,289
|
$11,083,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
441,620
|
$9,519,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
428,990
|
$9,245,000 | — | 30 Sep 2021 | |
| Jefferies Group LLC |
13F
|
Company |
1%
|
422,993
|
$9,115,499 | — | 30 Sep 2021 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.61%
|
260,000
|
$5,603,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.47%
|
200,000
|
$4,310,000 | — | 30 Sep 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.4%
|
170,000
|
$3,664,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.3%
|
126,802
|
$2,733,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
123,698
|
$2,665,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
74,011
|
$1,595,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
46,766
|
$1,008,000 | — | 30 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.11%
|
46,253
|
$997,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
28,614
|
$616,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
28,525
|
$615,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
26,480
|
$571,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
24,523
|
$529,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
21,763
|
$496,000 | — | 30 Sep 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.05%
|
22,198
|
$478,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
9,784
|
$210,000 | — | 30 Sep 2021 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
6,008
|
$129,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
5,881
|
$127,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,771
|
$125,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
5,417
|
$116,000 | — | 30 Sep 2021 | |
| Jason E. Tester |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,000
|
$109,900 | — | 15 Jun 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,614
|
$99,000 | — | 30 Sep 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
4,520
|
$97,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
3,237
|
$70,000 | — | 30 Sep 2021 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,100
|
$45,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
962
|
$21,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
925
|
$20,000 | — | 30 Sep 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
818
|
$18,000 | — | 30 Sep 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
515
|
$11,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
500
|
$11,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
465
|
$10,000 | — | 30 Sep 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
200
|
$4,000 | — | 30 Sep 2021 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
100
|
$2,000 | — | 30 Sep 2021 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
44
|
$1,000 | — | 30 Sep 2021 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
39
|
$840 | — | 30 Sep 2021 | |
| TUCKER ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
4
|
$111 | — | 30 Sep 2021 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q4 2021
As of 31 Dec 2021,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,072,993 shares.
The largest 10 holders included
Vivo Capital, LLC, RTW INVESTMENTS, LP, FRAZIER MANAGEMENT LLC, Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, BlackRock Inc., and Jefferies Group LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
43
Q4 2021 holders
43
Holder diff
0
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.